SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment
16 references·1 citing·39 second hop
Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment (2018)Availability and Affordability of Essenti…Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective (2018)Why Are We Failing to Address…Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases (2017)Baseline assessment of WHO’s …All roads lead to universal health coverage (2017)All roads lead to universal h…Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013 (2016)Expenditures and Prices of An…Constraints and challenges in access to insulin: a global perspective (2016)Constraints and challenges in…New Math on Drug Cost-Effectiveness (2015)New Math on Drug Cost-Effecti…Change in Medical Spending Attributable to Diabetes: National Data From 1987 to 2011 (2015)Change in Medical Spending At…Access to Diagnostic Tests and Essential Medicines for Cardiovascular Diseases and Diabetes Care: Cost, Availability and Affordability in the West Region of Cameroon (2014)Access to Diagnostic Tests an…Disparities in Diabetes: The Nexus of Race, Poverty, and Place (2013)Disparities in Diabetes: The …Tracking global funding for the prevention and control of noncommunicable diseases (2012)Tracking global funding for t…Practical measurement of affordability: an application to medicines (2012)Practical measurement of affo…Diabetes expenditure, burden of disease and management in 5 EU countries (2012)Diabetes expenditure, burden …The insulin dilemma in resource-limited countries. A way forward? (2010)The insulin dilemma in resour…Looking beyond the issue of access to insulin: What is needed for proper diabetes care in resource poor settings (2010)Looking beyond the issue of a…Access: how do good health technologies get to poor people in poor countries? (2009)Access: how do good health te…Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…Noncommunicable diseases, access to essential medicines and universal health coverage (2019)Noncommunicable diseases, acc…The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)Health systems financing and the path to universal coverage (2010)Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems (2021)The Truly Disadvantaged: The Inner City, The Underclass, and Public Policy. (1988)Racial Residential Segregation: A Fundamental Cause of Racial Disparities in Health (2001)Racial residential segregation: A fundamental cause of racial disparities in health (2001)Improving the health of African Americans in the USA: an overdue opportunity for social justice (2016)Social Determinants of Health and Diabetes: A Scientific Review (2020)Chronic Disease Prevalence in the US: Sociodemographic and Geographic Variations by Zip Code Tabulation Area (2024)Grand challenges in chronic non-communicable diseases (2007)Financing of global health: tracking development assistance for health from 1990 to 2007 (2009)A global view on the development of non communicable diseases (2011)Priority actions for the non-communicable disease crisis (2011)Multiple health behaviours: overview and implications (2012)Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; systematic review and meta-regression analyses (2017)The Discovery of Insulin (1982)Access to Essential Drugs in Poor Countries (1999)Insulin prices, availability and affordability in 13 low-income and middle-income countries (2019)The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries (2019)A global perspective on the issue of access to insulin (2021)Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration (2013)Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability (2020)Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries (2017)Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017)Migrant and refugee populations: a public health and policy perspective on a continuing global crisis (2018)Strengthening global health security by embedding the International Health Regulations requirements into national health systems (2018)The Scottish government (1998)The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)Costes directos de la diabetes mellitus y de sus complicaciones en España (Estudio SECCAID: Spain estimated cost Ciberdem-Cabimer in Diabetes) (2013)Pensions at a Glance (2014)The economic burden of diabetes in India: a review of the literature (2014)Healthcare costs of Type 2 diabetes in Germany (2017)THE WORLD MEDICINES SITUATION 2011 (2011)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)Creating Access To Health Technologies In Poor Countries (2009)Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico (2012)Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature (2017)Estimated Lifetime Economic Burden of Type 1 Diabetes (2019)
this work references cited by second hop

References

  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 2012Tracking global funding for the prevention and control of noncommunicable diseases606 cited
  • 2013Disparities in Diabetes: The Nexus of Race, Poverty, and Place443 cited
  • 2016Constraints and challenges in access to insulin: a global perspective187 cited
  • 2012Diabetes expenditure, burden of disease and management in 5 EU countries173 cited
  • 2017Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases159 cited
  • 2017All roads lead to universal health coverage144 cited
  • 2016Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013129 cited
  • 2009Access: how do good health technologies get to poor people in poor countries?107 cited
  • 2014Access to Diagnostic Tests and Essential Medicines for Cardiovascular Diseases and Diabetes Care: Cost, Availability and Affordability in the West Region of Cameroon93 cited
  • 2012Practical measurement of affordability: an application to medicines87 cited
  • 2010Looking beyond the issue of access to insulin: What is needed for proper diabetes care in resource poor settings86 cited
  • 2010The insulin dilemma in resource-limited countries. A way forward?76 cited
  • 2015

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Change in Medical Spending Attributable to Diabetes: National Data From 1987 to 2011
73 cited
  • 2015New Math on Drug Cost-Effectiveness71 cited
  • 2018Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective65 cited
  • Cited by

    • 2019Noncommunicable diseases, access to essential medicines and universal health coverage51 cited